Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 444, 796-797 (14 December 2006) | doi:10.1038/444796a; Published online 13 December 2006
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
- More Challenges
- Powered by:
nature jobs
Manager for the Recently Established Fly Facility
- Max-Planck-Institute of Immunobiology
- Freiburg Germany
Full-Professor of Heart and Thoracic Surgery (W3) (f / m)
- Friedrich-Schiller-University Jena
- Jena Germany
Agency set up to tackle bioterror
Meredith Wadman
Abstract
Last minute deals in Congress push through biodefence bill and give cash boost to NIH.
In a late-night flurry of activity as it rushed to adjourn, the US Congress last week created a new agency that will allocate $1 billion to companies that are developing drugs and vaccines to tackle bioterror and pandemic agents. Bleary-eyed lawmakers also passed legislation governing the broad workings of the National Institutes of Health (NIH) and authorizing a hefty budget boost for the biomedical agency over the next two years.
To read this story in full you will need to login or make a payment (see right).
